Our study presents a negative correlation between SERT expression and patient survival and demonstrates that SSRIs can activate human CD8 T cells and promote antitumor immunity in vitro and in vivo; however, clinical correlation data linking SSRI use to overall survival/ICB response in cancer patients remain lacking. The gene discussed is CD8A; the disease is cancer.